Aggression  >>  epirubicin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00854568: Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL

Completed
3
398
RoW
CEOP regimen, CEOP, CHOP regimen, CHOP
Fudan University
Lymphoma
12/12
02/13

Download Options